An Evaluation of Insulin Use in Hospitalized Patients with Corticosteroid-Related Hyperglycemia

Clicks: 18
ID: 332502
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #134 of 247 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 247 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Purpose This study evaluated insulin use in hospitalized patients who developed corticosteroid-related hyperglycemia to assess current insulin management strategies, glycemic outcomes, and opportunities for optimizing institutional practice. Methods This retrospective study was conducted at a community-based teaching health system and included hospitalized adults who experienced clinically significant hyperglycemia (blood glucose >250 mg/dL) on at least two occasions during admission between September 2024 and September 2025. The primary outcome was the percentage of patients administered intermediate or long-acting insulin following hyperglycemia. The secondary endpoints evaluated glycemic control, hypoglycemia, timing of insulin orders, and administration of optimized insulin regimens based on pharmacokinetics. This project was deemed exempt by the IRB. Results Of 1,361 patient encounters screened, 708 unique patients were included, and 610 had type II diabetes (T2DM). Intermediate or long-acting insulin was administered more frequently in patients with T2DM than those without (71.1% vs 41.8%, p<0.001). A minority of patients had insulin before or with the first dose of steroid (T2DM 35.1% vs without T2DM 13.3%). Glycemic control was achieved most frequently in patients without T2DM (52% vs 35%, p<0.001). Conclusions This study showed that a higher percentage of patients with T2DM received insulin before or with the first dose of steroid when compared to patients without T2DM. However, in both groups, a majority of patients received insulin after the first dose of steroid. Findings suggest that hospitalized adults with or without diabetes who develop corticosteroid-related hyperglycemia will benefit from receiving an intermediate or long-acting insulin concurrently with the ordered steroid.
Reference Key
openalex_W7222275803 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alexis Clarke, Sarah Ferrell, Blake Burton, Christina Ford, Elizabeth Meisberger
Are you one of these authors? Claim your profile
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag346
URL
https://doi.org/10.1093/ajhp/zxag346
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.